Crystal Adam

Chief Medical OfficerC4 Therapeutics, Inc. (CCCC) · full profile →Form 4 · filed Oct 5, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$681K
Net Open-Market Flow
-$681K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2021Sell(S)8K$45.32$371K5K
Oct 1, 2021Sell(S)2K$44.25$76K13K
Oct 1, 2021Sell(S)5K$45.99$235K0
Oct 1, 2021Option exercise(M)15K$4.98$75K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2021Option exercise(M)15K$0168K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-059512) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.